Women diagnosed with primary breast cancer in stages I, II or III;
40-65 years old at screening;
Cancer treatment (radiotherapy and chemotherapy) completed ≥ 6 months but not more than 10 years at the time of recruitment;
Currently consuming less than 2 avocados per week;
Signed the informed consent letter.
You may not be if
Metastasis;
Ductal carcinoma or lobular carcinoma in situ;
Breast cancer recurrence;
Cancer diagnosis other than breast cancer or non-melanoma skin cancer;
Body mass index ≥40kg/m2;
Currently pregnant or breastfeeding, or planning pregnancy in the following 6 months;
Allergy to latex;
Unwilling to consume avocado;
Immunodeficiency or HIV-positive status;
Alcohol abuse (\>50g/day);
Unstable use of plant sterols, mineral supplements, use of fibre supplements, fish oil, or antioxidants in the 4 weeks prior to enrolment, or plans to change this during the study;
Currently participating in any other randomized controlled trial;
Difficulty or impossibility of an adequate follow-up;
Inability or unwillingness to give written informed consent or to communicate with study personnel, or illiteracy;
Patients with an acute infection or inflammation (e.g., pneumonia) will be allowed to participate in the study 3 months after recovery.
Clareo Health | Avocado Consumption and Cellular Aging in Breast Cancer Survivors
